Bear Stearns Ups Pharma Resources Estimates

Analyst Joseph Riccardo likes the drug maker's strong profits from its generic Prilosec drug to treat acid reflux

Bear Stearns raised its estimates on Pharmaceutical Resources (PRX ).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.